COVID-19 vaccine in multiple sclerosis patients treated with disease-modifying therapies: a systematic review
Arquivos de Neuro-Psiquiatria · 01.08.2024 · 82 (S 01 S 01) · S1-S52
DOI: 10.1055/s-0044-1789378 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Arquivos de Neuro-Psiquiatria, erschienen am 01.08.2024. Verfasst von Vitória Alagia Ripari und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Address for correspondence: Vitória Alagia Ripari (email: vitoriaalagia@gmail.com).
Zitieren
APA
Ripari, V. A., Miranda, M. C., Duarte, A. C. D. S., & Ramos, D. S. (2024). COVID-19 vaccine in multiple sclerosis patients treated with disease-modifying therapies: a systematic review. Arquivos de Neuro-Psiquiatria, 82(S 01 S 01), S1-S52. https://doi.org/10.1055/s-0044-1789378
Vancouver
Ripari VA, Miranda MC, Duarte ACDS, Ramos DS. COVID-19 vaccine in multiple sclerosis patients treated with disease-modifying therapies: a systematic review. Arquivos de Neuro-Psiquiatria. 2024;82(S 01 S 01):S1-S52. doi:10.1055/s-0044-1789378
BibTeX
@article{Ripari2024,
author = {Ripari, Vitória Alagia and Miranda, Maria Constancio and Duarte, Aline Cristina da Silva and Ramos, Déborah Schulthais},
title = {COVID-19 vaccine in multiple sclerosis patients treated with disease-modifying therapies: a systematic review},
journal = {Arquivos de Neuro-Psiquiatria},
year = {2024},
volume = {82},
number = {S 01 S 01},
pages = {S1--S52},
doi = {10.1055/s-0044-1789378}
}
EUVIMED